Adebowale Adebiyi

Adebowale Adebiyi, PhD is a Professor of Medical Pharmacology & Physiology at the University of Missouri School of Medicine, where he holds the Russell D. and Mary B. Shelden Missouri Chair in Anesthesiology. He serves as a NextGen Precision Health Investigator with a focus on Vascular and Kidney Disorders, conducting research at the NextGen Precision Health Center in Columbia, Missouri.

Dr. Adebiyi's educational background includes:

• Postdoctoral Research Fellow, Department of Physiology, University of Tennessee Health Science Center (2009)
• PhD, National University of Singapore, Singapore (2004)
• Bachelor of Science (Honors), College of Medicine, University of Lagos, Nigeria (1996)

His research program focuses on renal and vascular pathophysiology in neonates and adults, utilizing an integrative approach that combines molecular, biochemical, electrophysiology, imaging, and whole animal methodologies. Dr. Adebiyi's laboratory specializes in investigating ion channels, G protein-coupled receptors, oxyradicals, and regulatory proteins that control vascular and kidney function. A significant contribution to the field is his development of translational swine models to study vascular and kidney disease, with particular emphasis on neonatal renal microcirculation. His laboratory is among the few research groups worldwide that utilize translational swine models to investigate kidney microcirculation and dysfunction within the first week of life.

Analysis of Dr. Adebiyi's publication record reveals a consistent focus on renal vascular physiology, with particular emphasis on TRP channels in kidney function, mechanisms of acute kidney injury, and the development of novel diagnostic tools and therapeutic targets. His work spans basic science investigations to translational research with clinical applications, especially in the areas of neonatal kidney function, sickle cell nephropathy, and diabetes-related kidney complications. Recent publications demonstrate growing interest in biomarker development and novel therapeutic targets for kidney diseases.

Dr. Adebiyi's significant contributions to the field have been recognized through numerous awards:

• Outstanding Reviewer Award: Experimental Biology and Medicine (2020)
• John F. Perkins, Jr. Research Career Enhancement Award: American Physiological Society (2020)
• Publication recommendation: Faculty of 1000 - Renal, Fluid & Electrolyte Physiology (2019)
• University of Tennessee Research Foundation Technology Maturation Award (2018)
• American Heart Association Research Leaders Academy selection (2017)
• Research Recognition Award: American Physiological Society Renal Section (2013)

Dr. Adebiyi's research has been consistently supported by NIH funding, with recent projects using swine models to explore the physiology and pathophysiology of neonatal renal microcirculation. His laboratory investigates the mechanisms underlying vascular and kidney function with the goal of developing novel therapeutic and diagnostic approaches. He anticipates his research will yield findings with significant clinical impact for patients with vascular and kidney disorders.

Based at the NextGen Precision Health Center, Dr. Adebiyi's laboratory is equipped to study vascular and kidney pathophysiology using small and large animal disease models, including hypertension, acute kidney injury, chronic kidney disease, diabetic kidney disease, and sickle cell nephropathy. His work represents a critical bridge between basic science discoveries and clinical applications in renal and vascular medicine.